Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2010
10/06/2010CN1681508B Novel inhibitors of kinases
10/06/2010CN1646684B Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
10/06/2010CN1606444B Inhibitors of human phosphatidyl-inositol 3-kinase delta
10/06/2010CN1520300B Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/06/2010CN101855339A Human cancer stem cells
10/06/2010CN101855208A 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof
10/06/2010CN101854943A Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan)
10/06/2010CN101852781A HPLC analysis and detection method of cyclosporine A
10/06/2010CN101851593A Lactobacillus planetarium strain LP28 and application thereof in mitigation of anaphylactic reaction
10/06/2010CN101851300A Process for extracting chondroitin sulfate
10/06/2010CN101851291A Heavy chain and light chain variable regions of anti-human BAFF monoclonal antibody
10/06/2010CN101851275A Dimerized peptide
10/06/2010CN101851238A Substituted 8-heteroaryl xanthines
10/06/2010CN101851191A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
10/06/2010CN101850105A Cefuroxime sodium composite medicine
10/06/2010CN101850066A Chinese medicinal composition granules and preparation method thereof
10/06/2010CN101850057A Vital nourishing ant wine and preparation method thereof
10/06/2010CN101850052A Immunity-enhancing pharmaceutical composition and preparation method thereof
10/06/2010CN101850029A Tortoise shell ginseng healthcare spirit and preparation method thereof
10/06/2010CN101850027A Pharmaceutical composition with functions of radiation resistance and immunity enhancement and preparation method thereof
10/06/2010CN101849991A Magnolia biondii pamp volatile oil nanoliposome freeze-dried powder, temperature-sensitive magnolia biondii pamp nanogel and preparation method thereof
10/06/2010CN101849986A Immunopotentiator for weaning piglets and application thereof
10/06/2010CN101849972A Banding detection method of Cordyceps sinensis DNA fingerprint high resolution ratio
10/06/2010CN101849964A Method for preparing artemia egg micro powder and application thereof in healthcare products
10/06/2010CN101849924A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
10/06/2010CN101849902A Preparation method of solid pharmaceutical composition containing desloratadine
10/06/2010CN101849889A Fragrance-lasting natural essential oil nanoemulsion used for cosmetology and SPA (essential oil therapy) and preparation method thereof
10/06/2010CN101129362B Sirolimus dispersible tablets and method of producing the same
10/06/2010CN101120915B Dexamethasone sodium phosphate injection
10/06/2010CN101019909B Supercritical safflower extracting process
10/06/2010CN100998857B Kidney tonifying and enriching blood health-care tea and its preparation method
10/05/2010US7807854 administering diaryl sulfide or diaryl ether compound having a 2-amino-1,3-propanediol structure such as 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl-1,3-propanediol, in combination with an immunosuppressant and/or an antiinflammatory agent, for the for treatment autoimmune diseases
10/05/2010US7807805 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
10/05/2010US7807689 such as 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile, used for the treatment of breast cancer and non-insulin depepndent diabetes
10/05/2010US7807688 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders
10/05/2010US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases
10/05/2010US7807656 Pharmaceutical applications of hyaluronic acid preparations
10/05/2010US7807463 Pretreatment of animal with antibodies to sensitize animal; controlling dosage
10/05/2010US7807441 Nucleotide sequences which code protein that induces cytotoxic T-lymphocyte immunity against weak selfproteins; antitumor agents
10/05/2010US7807191 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/05/2010US7807170 Modulating an immune response in a subject by administering an effective amount of a lymphocyte differentiation factor; antiinflammatory agents
10/05/2010US7807169 Stratified and cryogenically stored vaccines, process for their preparation
10/05/2010US7807142 comprising interleukin-2 (IL-2); using an amino acid base sufficient to decrease aggregate formation of the polypeptide during storage of the composition, and a buffering agent ; mixture with amino acid and buffer
10/05/2010CA2506803C Functional domain and associated molecule of dock2 essentially required in lymphocyte migration
10/05/2010CA2455167C New pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
10/05/2010CA2436233C Perylenequinones for use with immunotherapy agents
10/05/2010CA2367138C Anti-inflammatory uses of manzamines
10/05/2010CA2322516C Sustained release macrolide compositions
10/05/2010CA2086325C Ligand for cd28 receptor on b cells and methods
09/2010
09/30/2010WO2010111527A1 Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
09/30/2010WO2010111485A1 Compositions for stimulation of mammalian innate immune resistance to pathogens
09/30/2010WO2010110408A1 Dna vaccine for alzheimer's disease
09/30/2010WO2010110045A1 Process for producing lactic acid bacterium having enhanced immunomodulating activity
09/30/2010WO2010108215A1 Compounds and methods for modulating an immune response
09/30/2010WO2010089510A3 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
09/30/2010US20100249217 Modulators of pharmacological agents
09/30/2010US20100249195 Pyridylphenyl compounds for inflammation and immune-related uses
09/30/2010US20100249187 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
09/30/2010US20100249174 Ccr1 antagonists and methods of use therefor
09/30/2010US20100249155 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
09/30/2010US20100249131 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
09/30/2010US20100249129 Compounds as cannabinoid receptor ligands
09/30/2010US20100249118 Compounds and methods for kinase modulation, and indications therefor
09/30/2010US20100249098 Oxypiperidine derivatives and methods of use thereof
09/30/2010US20100249092 Heteroaryl compounds and uses thereof
09/30/2010US20100249087 Compounds as cannabinoid receptor ligands
09/30/2010US20100249086 Compounds As Cannabinoid Receptor Ligands
09/30/2010US20100249082 Modulators of hypoxia inducible factor-1 and related uses
09/30/2010US20100249078 Tetracyclic inhibitors of fatty acid amide hydrolase
09/30/2010US20100249071 Modulators of S1P and Methods of Making And Using
09/30/2010US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses
09/30/2010US20100249019 Use of a peptide as a therapeutic agent
09/30/2010US20100249017 Use of cnp-22, alone or in combination with physalemin, as a therapeutic agent
09/30/2010US20100247668 Polymer-agent conjugates, particles, compositions, and related methods of use
09/30/2010US20100247661 Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
09/30/2010US20100247604 Method of treatment of connective tissues and organs and uses of said tissues and organs
09/30/2010US20100247577 Tr1 cells, mesenchymal stem cells and uses thereof
09/30/2010US20100247575 Agents for promoting iga production
09/30/2010US20100247572 Viruses encoding mutant membrane protein
09/30/2010US20100247566 Cholera vaccines
09/30/2010US20100247561 Polypeptides for inducing a protective immune response against staphylococcus aureus
09/30/2010US20100247554 Use of tam receptor inhibitors as antimicrobials
09/30/2010US20100247553 Goodpasture Antigen Binding Protein
09/30/2010US20100247547 Modulation of the th-17 cell mediated immune responses
09/30/2010US20100247535 Chemically Programmable Immunity
09/30/2010US20100247534 Fused heterocyclic compounds as inhibitors of potassium channel function
09/30/2010US20100247527 Composition and method for treatment of autoimmune disease
09/30/2010US20100247523 Subtypes of humanized antibody against interleuken-6 receptor
09/30/2010US20100247521 Therapeutic and Diagnostic Methods Using TIM-3
09/30/2010US20100247518 Modified proteins, designer toxins, and methods of making thereof
09/30/2010US20100247500 Agent and method for improving survivability of lactic acid bacterium, and food composition
09/30/2010US20100247497 Vector particles for targetng cd34+ cells
09/30/2010US20100247482 Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compounds
09/30/2010US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/2010US20100247440 Mycobacterial immunotherapy for cancer treatment
09/30/2010US20100247430 Methods and Compositions for Modulating T Cells
09/30/2010CA2756883A1 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
09/30/2010CA2756729A1 Method for producing lactic acid bacteria having enhanced immunoregulating activities
09/30/2010CA2756412A1 Compositions for stimulation of mammalian innate immune resistance to pathogens
09/30/2010CA2756170A1 Glycoconjugate vaccines
1 ... 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 ... 1172